David R. Horn, Director at EDAP TMS SA (EDAP), bought 10,000 shares at $4.75 ($48K) on 2026-08-14, disclosed to the SEC on 2026-08-17.
Director David R. Horn purchased $47,500 worth of EDAP shares at $4.75, marking the largest insider purchase in the company's history. This significant accumulation by a director during a period of stock underperformance suggests confidence in the company's strategic pivot and recent operational momentum.
EDAP shares are trading near the bottom of their 52-week range, currently 5.28% below the 52-week high of $4.45 and down 4.2% over the last 90 days. The stock is currently priced at $4.215, representing a 35.1% premium to the 52-week low of $3.12.
1) FocalTherics Investor Day on June 1, 2026, where management outlined a shift to a high-growth pure-play robotic focal therapy company. 2) Q1 2026 earnings on May 7, 2026, which management described as a 'strong first quarter' with record revenue and continued momentum in the HIFU business. 3) The company's largest-ever insider purchase on August 14, 2026, signaling strong conviction from leadership.
The stock is currently trading 5.28% below its 52-week high, indicating that the recent insider purchase is occurring at a time when the stock has already pulled back from recent highs.
Nothing distinguishes this filing.
| Filing → |
| SEER | SELL | 2026-02-19 | $15K | — | Filing → |
| SEER | SELL | 2025-11-21 | $13K | — | Filing → |
| SEER | SELL | 2025-08-21 | $14K | — | Filing → |